Calcitonin gene related peptide receptor antagonists

Details for Australian Patent Application No. 2003237255 (hide)

Owner Bristol-Myers Squibb Company

Inventors Karageorge, George N.; Chaturvedula, Prasad V.; Vig, Shikha; Han, Xiaojun; Chen, Ling; Poindexter, Graham; Civiello, Rita; Dubochik, Gene M.; Macor, John E.; Conway, Charles Mark; Degnan, Andrew P.; Luo, Guanglin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003237255

PCT Number PCT/US03/16576

PCT Pub. Number WO2003/104236

Priority 60/388,617 13.06.02 US; 60/413,534 25.09.02 US; 60/389,870 19.06.02 US; 60/393,200 01.07.02 US; 60/386,138 05.06.02 US

Filing date 27 May 2003

Wipo publication date 22 December 2003

Acceptance publication date 17 December 2009

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/527 (2006.01) - spiro-condensed

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/5377 (2006.01)

A61K 49/00 (2006.01) Preparations for testing

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/12 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/388,617 13.06.02 US; 60/413,534 25.09.02 US; 60/389,870 19.06.02 US; 60/393,200 01.07.02 US; 60/386,138 05.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-B-2003237255

17 December 2009 Application Accepted

  Published as AU-B-2003237255

7 January 2010 Corrigenda

  Applications Accepted - Name Index Under the name Bristol-Myers Squibb Company, Application No. 2003237255, under INID (72), correct the coinventor to Dubowchik, Gene M.

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003237256-SUPPLEMENTAL ANIMAL INFORMATION TAG

2003237254-RECLINER HANDLE EXTENDER